Owens & Minor (OMI) Competitors $7.25 +0.10 (+1.40%) As of 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock OMI vs. MCK, COR, CAH, HSIC, PDCO, VCYT, AMRX, DNLI, BCRX, and BHVNShould you be buying Owens & Minor stock or one of its competitors? The main competitors of Owens & Minor include McKesson (MCK), Cencora (COR), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO), Veracyte (VCYT), Amneal Pharmaceuticals (AMRX), Denali Therapeutics (DNLI), BioCryst Pharmaceuticals (BCRX), and Biohaven (BHVN). These companies are all part of the "medical" sector. Owens & Minor vs. McKesson Cencora Cardinal Health Henry Schein Patterson Companies Veracyte Amneal Pharmaceuticals Denali Therapeutics BioCryst Pharmaceuticals Biohaven Owens & Minor (NYSE:OMI) and McKesson (NYSE:MCK) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, media sentiment, community ranking, dividends, risk, institutional ownership and earnings. Which has preferable valuation and earnings, OMI or MCK? McKesson has higher revenue and earnings than Owens & Minor. Owens & Minor is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOwens & Minor$10.70B0.05-$41.30M-$4.75-1.49McKesson$344.58B0.25$3.00B$21.8431.61 Which has more risk and volatility, OMI or MCK? Owens & Minor has a beta of 1.38, meaning that its stock price is 38% more volatile than the S&P 500. Comparatively, McKesson has a beta of 0.53, meaning that its stock price is 47% less volatile than the S&P 500. Does the MarketBeat Community prefer OMI or MCK? McKesson received 720 more outperform votes than Owens & Minor when rated by MarketBeat users. Likewise, 74.24% of users gave McKesson an outperform vote while only 48.04% of users gave Owens & Minor an outperform vote. CompanyUnderperformOutperformOwens & MinorOutperform Votes25748.04% Underperform Votes27851.96% McKessonOutperform Votes97774.24% Underperform Votes33925.76% Do insiders and institutionals hold more shares of OMI or MCK? 98.0% of Owens & Minor shares are owned by institutional investors. Comparatively, 85.1% of McKesson shares are owned by institutional investors. 3.7% of Owens & Minor shares are owned by company insiders. Comparatively, 0.1% of McKesson shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Do analysts rate OMI or MCK? Owens & Minor currently has a consensus price target of $12.50, suggesting a potential upside of 76.06%. McKesson has a consensus price target of $686.69, suggesting a potential downside of 0.52%. Given Owens & Minor's higher possible upside, research analysts plainly believe Owens & Minor is more favorable than McKesson.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Owens & Minor 2 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.00McKesson 0 Sell rating(s) 3 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 2.87 Does the media favor OMI or MCK? In the previous week, McKesson had 39 more articles in the media than Owens & Minor. MarketBeat recorded 64 mentions for McKesson and 25 mentions for Owens & Minor. McKesson's average media sentiment score of 1.11 beat Owens & Minor's score of 0.75 indicating that McKesson is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Owens & Minor 6 Very Positive mention(s) 4 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive McKesson 34 Very Positive mention(s) 5 Positive mention(s) 14 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive Is OMI or MCK more profitable? McKesson has a net margin of 0.82% compared to Owens & Minor's net margin of -0.46%. Owens & Minor's return on equity of 14.60% beat McKesson's return on equity.Company Net Margins Return on Equity Return on Assets Owens & Minor-0.46% 14.60% 2.51% McKesson 0.82%-181.26%5.34% SummaryMcKesson beats Owens & Minor on 14 of the 19 factors compared between the two stocks. Get Owens & Minor News Delivered to You Automatically Sign up to receive the latest news and ratings for OMI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OMI vs. The Competition Export to ExcelMetricOwens & MinorMedical & hospital equipment IndustryMedical SectorNYSE ExchangeMarket Cap$553.53M$8.00B$5.43B$19.40BDividend YieldN/A1.98%5.44%3.95%P/E Ratio-11.0221.7525.6534.59Price / Sales0.051.17405.2634.72Price / Cash1.2510.7638.3117.51Price / Book0.592.156.724.70Net Income-$41.30M$259.21M$3.23B$1.02B7 Day Performance-8.15%-1.21%2.66%4.31%1 Month Performance2.90%3.89%10.86%10.92%1 Year Performance-62.05%-7.78%15.50%6.01% Owens & Minor Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OMIOwens & Minor4.787 of 5 stars$7.25+1.4%$12.50+72.4%-61.6%$560.10M$10.70B-11.1522,500Earnings ReportAnalyst RevisionMCKMcKesson4.4087 of 5 stars$706.68-0.2%$681.00-3.6%+22.7%$88.57B$344.58B32.3675,000Earnings ReportAnalyst RevisionPositive NewsCORCencora4.6389 of 5 stars$291.80-0.1%$290.00-0.6%+23.9%$56.58B$638.56M41.5142,000Earnings ReportDividend AnnouncementPositive NewsCAHCardinal Health4.6948 of 5 stars$151.73+1.5%$146.43-3.5%+49.2%$36.65B$222.28B28.3146,500Positive NewsHSICHenry Schein3.1474 of 5 stars$66.58+2.0%$80.20+20.5%-3.9%$8.16B$12.67B27.4022,000PDCOPatterson Companies1.9891 of 5 stars$31.33flat$26.57-15.2%N/A$2.77B$6.51B18.327,700VCYTVeracyte3.8971 of 5 stars$31.32+3.2%$42.60+36.0%+43.9%$2.45B$445.76M-208.80790AMRXAmneal Pharmaceuticals3.0094 of 5 stars$7.54-5.4%$10.80+43.2%+14.1%$2.34B$2.79B-11.097,600Analyst DowngradePositive NewsDNLIDenali Therapeutics4.4057 of 5 stars$15.99-2.7%$37.57+135.0%-19.2%$2.32B$330.53M-5.79430Earnings ReportAnalyst RevisionNews CoverageBCRXBioCryst Pharmaceuticals4.6836 of 5 stars$11.03+23.5%$16.13+46.2%+94.4%$2.31B$450.71M-18.08530High Trading VolumeBHVNBiohaven3.6485 of 5 stars$22.59-1.1%$62.54+176.8%-42.7%$2.31BN/A-2.42239Earnings ReportAnalyst Forecast Related Companies and Tools Related Companies McKesson Alternatives Cencora Alternatives Cardinal Health Alternatives Henry Schein Alternatives Patterson Companies Alternatives Veracyte Alternatives Amneal Pharmaceuticals Alternatives Denali Therapeutics Alternatives BioCryst Pharmaceuticals Alternatives Biohaven Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:OMI) was last updated on 5/13/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredWarning: Massive IPO Predicted for May 14?The #1 venture capitalist in America predicts that the biggest IPO in history will take place on Wednesday, Ma...Paradigm Press | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Owens & Minor, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Owens & Minor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.